Clioquinol
- Generic Name
- Clioquinol
- Brand Names
- Locacorten Vioform
- Drug Type
- Small Molecule
- Chemical Formula
- C9H5ClINO
- CAS Number
- 130-26-7
- Unique Ingredient Identifier
- 7BHQ856EJ5
- Background
Clioquinol was withdrawn in 1983 due to neurotoxicity.
- Indication
Used as a topical antifungal treatment.
- Associated Conditions
- Acne, Atopic Dermatitis, Contact Dermatitis, Dermatosis, Eczema impetiginous, Eczema of the nuchal nape of the neck, Folliculitis, Fungal ear infection caused by Aspergillus niger, Infantile Eczema, Inflammation, Intertrigo, Lichen simplex chronicus, Moniliasis, Nummular Dermatitis, Otitis Externa, Pruritis of the scroti, Pruritus Ani, Pruritus Vulvae, Pyoderma, Stasis dermatitis, Tinea Capitis, Tinea Corporis, Tinea Cruris, Tinea Pedis, Bacterial skin infections, Chronic otitis externa, Corticosteroid-responsive dermatoses, Disseminated Neurodermatitis, Localized Neurodermatitis
- Associated Therapies
- -
Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 10
- Registration Number
- NCT05727943
- Locations
- 🇧🇪
University Hospitals UZ Leuven, Leuven, Belgium
Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 11
- Registration Number
- NCT00963495
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath